MedTrace Logo

Retrospective Review of Integrity Implants FlareHawk® for Lumbar Fusion

NCT04057235 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2020-04-21

Study results available
· View outcomes & findings →

Summary

This is a retrospective clinical study (chart review) of patients who have previously undergone Transforaminal Lumbar Interbody Fusion or Posterior Lumbar Interbody Fusion surgery with the FlareHawk expandable interbody fusion cage at one or two contiguous levels.

Conditions

  • Degenerative Disc Disease

Interventions

DEVICE

FlareHawk Interbody Fusion System

Expandable lumbar intervertebral body fusion device

Sponsors & Collaborators

  • Integrity Implants Inc.

    lead INDUSTRY

Principal Investigators

  • Domagoj Coric, MD · Carolina Neurosurgery & Spine Associates, Charlotte, NC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-23
Primary Completion
2019-12-13
Completion
2019-12-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04057235 on ClinicalTrials.gov